Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Shingles in the COVID-19 Era: Vaccination for Prevention of Complications—Audio Recap

What are common complications of shingles? How effective is shingles vaccination at preventing postherpetic neuralgia? Listen to expert insights from Dalilah Restrepo, MD, on shingles complications and how healthcare professionals can help their patients catch up on shingles vaccinations delayed due to the COVID-19 pandemic.
person default
Dalilah Restrepo, MD
Released: November 23, 2021

In this episode, Dalilah Restrepo, MD, discusses expert guidance on vaccination for the prevention of shingles complications in the COVID-19 era.

Using a case study and the latest expert guidance, this podcast covers topics such as:

  • Expert guidance on maintenance of routine vaccination during the COVID-19 era
  • Common shingles complications in immunocompetent patients
  • Additional shingles complications in immunocompromised patients
  • Guidance on safe shingles vaccine delivery during the COVID-19 pandemic
  • CDC guidance catching up after RZV dosing delays 

Information on this Educational Activity

Faculty

Dalilah Restrepo, MD

Infectious Diseases Specialist
Fountain Valley Hospital
Fountain Valley, California

Dalilah Restrepo, MD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
GlaxoSmithKline

Related Content

Clinical Care Options (CCO) podcast with Dr. Renslow Sherer on oral antiviral agents for nonhospitalized adults with mild to moderate COVID-19

Renslow Sherer, MD Released: January 6, 2022

Download slides reviewing the latest data and guidance on COVID-19 symptoms and clinical manifestations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: January 6, 2022

Download slides reviewing the latest data and guidance on COVID-19 prevention and treatment in special populations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: January 6, 2022

Prof. Sharon R. Lewin gives expert insight on IV and oral antiviral agents for nonhospitalized patients with COVID-19, from Clinical Care Options (CCO)

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: January 6, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings